Citation Tools
PDFRegular Abstracts – Part 2
Clinical Trial In Progress
782-D Systemic delivery of novel, allosteric STING agonist CRD3874-SI leads to robust anti-cancer activity by generating pro-inflammatory Type I IFN signals while blocking proton channel mediated toxicity
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 782-D Systemic delivery of novel, allosteric STING agonist CRD3874-SI leads to robust anti-cancer activity by generating pro-inflammatory Type I IFN signals while blocking proton channel mediated toxicity